450 related articles for article (PubMed ID: 23230433)
1. Good news-bad news: the Yin and Yang of immune privilege in the eye.
Forrester JV; Xu H
Front Immunol; 2012; 3():338. PubMed ID: 23230433
[TBL] [Abstract][Full Text] [Related]
2. Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.
Wang X; Wang T; Lam E; Alvarez D; Sun Y
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569464
[TBL] [Abstract][Full Text] [Related]
3. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
Streilein JW
Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
[TBL] [Abstract][Full Text] [Related]
4. Immune Privilege: The Microbiome and Uveitis.
Mölzer C; Heissigerova J; Wilson HM; Kuffova L; Forrester JV
Front Immunol; 2020; 11():608377. PubMed ID: 33569055
[TBL] [Abstract][Full Text] [Related]
5. Immune privilege in the anterior chamber of the eye.
Niederkorn JY
Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
[TBL] [Abstract][Full Text] [Related]
6. Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
Khatami M
Clin Transl Med; 2016 Dec; 5(1):35. PubMed ID: 27558401
[TBL] [Abstract][Full Text] [Related]
7. Ocular Immune Privilege and Transplantation.
Taylor AW
Front Immunol; 2016; 7():37. PubMed ID: 26904026
[TBL] [Abstract][Full Text] [Related]
8. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
Streilein JW
J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immune privilege in the eye and hair follicle.
Niederkorn JY
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):168-72. PubMed ID: 14582667
[TBL] [Abstract][Full Text] [Related]
10. Immune privilege or privileged immunity?
Forrester JV; Xu H; Lambe T; Cornall R
Mucosal Immunol; 2008 Sep; 1(5):372-81. PubMed ID: 19079201
[TBL] [Abstract][Full Text] [Related]
11. Immune Privilege and Eye-Derived T-Regulatory Cells.
Keino H; Horie S; Sugita S
J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
[TBL] [Abstract][Full Text] [Related]
12. Ocular immune privilege sites.
Masli S; Vega JL
Methods Mol Biol; 2011; 677():449-58. PubMed ID: 20941626
[TBL] [Abstract][Full Text] [Related]
13. Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.
Teabagy S; Wood E; Bilsbury E; Doherty S; Janardhana P; Lee DJ
Adv Drug Deliv Rev; 2023 Jul; 198():114869. PubMed ID: 37172782
[TBL] [Abstract][Full Text] [Related]
14. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.
Streilein JW; Takeuchi M; Taylor AW
Hum Immunol; 1997 Feb; 52(2):138-43. PubMed ID: 9077562
[TBL] [Abstract][Full Text] [Related]
15. Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?
Niederkorn JY
Front Immunol; 2012; 3():148. PubMed ID: 22707951
[TBL] [Abstract][Full Text] [Related]
16. Can the hair follicle become a model for studying selected aspects of human ocular immune privilege?
Kinori M; Kloepper JE; Paus R
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4447-58. PubMed ID: 21700717
[TBL] [Abstract][Full Text] [Related]
17. Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.
Schurmans LR; Diehl L; den Boer AT; Sutmuller RP; Boonman ZF; Medema JP; van der Voort EI; Laman J; Melief CJ; Jager MJ; Toes RE
J Immunol; 2001 Nov; 167(10):5832-7. PubMed ID: 11698457
[TBL] [Abstract][Full Text] [Related]
18. Ocular immune privilege.
Taylor AW
Eye (Lond); 2009 Oct; 23(10):1885-9. PubMed ID: 19136922
[TBL] [Abstract][Full Text] [Related]
19. Ocular autoimmunity: the price of privilege?
Caspi RR
Immunol Rev; 2006 Oct; 213():23-35. PubMed ID: 16972894
[TBL] [Abstract][Full Text] [Related]
20. The alchemy of immune privilege explored from a neuroimmunological perspective.
Arck PC; Gilhar A; Bienenstock J; Paus R
Curr Opin Pharmacol; 2008 Aug; 8(4):480-9. PubMed ID: 18603017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
